If you want to invest in stocks and do well at it, you need to choose your holdings carefully. There are two key factors to keep in mind -- quality and price.
Imagine buying a home, or a car, or even a pair of shoes. You probably won't just buy the loveliest house you see -- as you may not be able to afford it. You probably won't buy the cheapest car you can find, either, because it's not likely to perform well. It's the same when you target stock bargains. A true bargain will be both attractively priced and high-quality.
Seek high quality
Quality matters when you want to target stock bargains, because a high-quality company will have sustainable competitive advantages that will help it keep performing well. Its size might give it economies of scale, for example, or might have consumers sort of locked into its system and reluctant to switch. That can happen with email service providers, as it's a headache to send everyone your new email address. Or consider robotic surgery giant Intuitive Surgical (NASDAQ: ISRG ) . Once a hospital buys its machines, it won't be likely to buy one from a competing company, as its doctors will have learned how to use Intuitive's machines. Meanwhile, Intuitive will get to collect a lot of recurring revenue from the hospital, in the form of service contracts and supplies for the machines.
Top 10 Performing Stocks To Buy For 2014: AcelRx Pharmaceuticals Inc.(ACRX)
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain in the United States. The company develops ARX-01, a Sufentanil NanoTab PCA system, which completed Phase II clinical trial for acute post-operative pain. The Sufentanil NanoTab PCA system consists of sufentanil, a high therapeutic index opioid; NanoTabs, a non-invasive sublingual dosage form; and a handheld PCA device that enables simple patient-controlled delivery of NanoTabs in the hospital setting and eliminates the risk of programming errors. Its products also include ARX-02, a Sufentanil NanoTab BTP Management System that completed Phase II clinical trial for the treatment of cancer breakthrough pain; and ARX-03, a Sufentanil/Triazolam NanoTab, which completed Phase II clinical trial to provide mild sedation, anxiety reduction, and pain relief for patients undergoing painful procedures in a ph ysician?s office. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Redwood, California.
Advisors' Opinion:- [By StockMatusow]
One company that had an offering received very well is AcelRx Pharmaceuticals (ACRX). AcelRx is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. On July 19, 2013, AcelRx offered 570,000 shares priced at $11.65. Investors aggressively bought the offering and the stock now sits at $11.96 per share. We covered AcelRx this year when it was about $6.50 per share. It reached highs since of $13.50, which effectively makes it more than a double.
- [By Roberto Pedone]
One stock that's starting to trend within range of triggering a near-term breakout trade is AcelRx Pharmaceuticals (ACRX), which is involved in the development and commercialization of therapies for the treatment of acute and breakthrough pain. This stock has been on fire so far in 2013, with shares up big by 150%.
If you take a look at the chart for AcelRx Pharmaceuticals, you'll notice that this stock has been uptrending modestly for the last month and change, with shares moving higher from its low of $8.94 to its recent high of $11.52 a share. During that uptrend, shares of ACRX have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of ACRX within range of triggering a near-term breakout trade.
Traders should now look for long-biased trades in ACRX if it manages to break out above some near-term overhead resistance levels at $11.36 to $11.52 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 635,439 shares. If that breakout hits soon, then ACRX will set up to re-test or possibly take out its next major overhead resistance levels at $12.50 to its all-time high at $13.50 a share. Any high-volume move above $13.50 will then give ACRX a chance to tag $15 a share.
Traders can look to buy ACRX off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $10.35 to $10 a share. One can also buy ACRX off strength once it takes out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Eric Volkman]
AcelRx (NASDAQ: ACRX ) is going to market for a fresh round of funding. The company announced it will float shares of its common stock in an underwritten public flotation. Additionally, the firm expects to grant the issue's underwriters a 30-day purchase option for up to an additional 15% of the total amount of the shares in the offering.
Top 10 Performing Stocks To Buy For 2014: Syms Corp(SYMS)
Syms Corp operates a chain of ?off-price? apparel retail stores under the Syms and Filene?s Basement names in the United States. Its stores offer a range of in-season merchandise for men, women, and children. The company?s in-season merchandise includes men?s tailored clothing and haberdashery; women?s dresses, suits, and separates; children?s apparel; and men?s, women?s, and children?s shoes. Its Filene?s stores also offer a selection of jewelry and home goods. As of August 28, 2010, the company operated a chain of 48 off-price apparel stores located predominantly on the east coast. Syms Corp was founded in 1959 and is headquartered in Secaucus, New Jersey.
Top 10 Value Stocks To Invest In Right Now: Prana Biotechnology Ltd(PBT.AX)
Prana Biotechnology Limited engages in the research and development of therapeutic drugs for neurological diseases in Australia. It primarily focuses on the Alzheimer?s, Parkinson?s, and Huntington?s diseases, as well as various cancer, age-related macular degeneration and cataract, Motor Neuron, Creutzfeldt-Jakob, and other neurodegenerative diseases. The company?s development stage product line includes PBT2, a phase IIb clinical product intended for the Alzheimer?s disease; and PBT2, a phase II clinical trial product for the Huntington?s disease. Its other products comprise PBT434 for the Parkinson?s disease; and PBT519 for brain cancer. The company was formerly known as Prana Corporation Ltd. and changed its name to Prana Biotechnology Limited in January 2000. Prana Biotechnology Limited was founded in 1997 and is based in Parkville, Australia.
Top 10 Performing Stocks To Buy For 2014: Innospec Inc.(IOSP)
Innospec Inc. develops, manufactures, blends, and markets fuel additives, personal care and fragrance products, and other specialty chemicals to oil refineries, personal care and fragrance companies, and other chemical and industrial companies worldwide. The company operates in three segments: Fuel Specialties, Active Chemicals, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels. This segment?s products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating and diesel particulate filter systems. The Active Chemicals segment provides technology-based solutions for its customers? processes and products focused in personal care; household, industrial, and institutional; and fragrance ingredients markets. The Octane Additives segment produces and sells tetra ethyl lead for use in automotive gasoline. This segment is also involved in an enviro nmental remediation business that assists customers to manage the clean up of the associated redundant plants. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Littleton, Colorado.
Top 10 Performing Stocks To Buy For 2014: Premium Exploration Inc (PEM.V)
Premium Exploration Inc., an exploration stage company, engages in the exploration and development of various precious metal properties in the United States. It primarily explores for gold, platinum, palladium, and rhodium. The company holds titles in the Idaho Gold project located in the Orogrande Shear Zone in North-Central Idaho. Its properties also include the Chrome Mountain property located in South-Central Montana. Premium Exploration Inc. was incorporated in 2004 and is based in Vancouver, Canada.
Top 10 Performing Stocks To Buy For 2014: Fti Foodtech International Inc. (FTI.V)
FTI Foodtech International Inc. operates in the surplus goods industry. The company has multiple products and multiple buyers. It operates the Toronto office of the North American Barter Exchange Limited (NABEL) that provides business to business communications for its members� products and services. FTI Foodtech International, through NABEL, has access to hundreds of member-companies that provide products and services in North America. In addition, the company distributes Ageless, an oxygen absorber, to new and existing clients. FTI Foodtech International Inc. is headquartered in Don Mills, Canada.
Top 10 Performing Stocks To Buy For 2014: Goldcorp Incorporated(GG)
Goldcorp Inc. engages in the acquisition, exploration, development, and operation of precious metal properties in Canada, the United States, Mexico, and Central and South America. It produces and sells gold, silver, copper, lead, and zinc. The company was founded in 1954 and is headquartered in Vancouver, Canada.
Advisors' Opinion:- [By Doug Ehrman]
Due to gold's recent plunge marking its largest percentage drop since 1980, the explosive volume in the SPDR Gold Trust (NYSEMKT: GLD ) , and many swirling global macroeconomic factors, the precious yellow metal has spooked investors. The decline has not been limited to the commodity, as miners like Goldcorp (NYSE: GG ) , Barrick Gold (NYSE: ABX ) , and Newmont Mining (NYSE: NEM ) are experiencing precipitous declines as well. Adding to the concern is the fact that investors have been unable to pinpoint the precise cause of the collapse.
- [By Doug Ehrman]
More fundamental to the structural shift in the market is that after an extended period of underperformance by gold miners such as Goldcorp (NYSE: GG ) and Newmont Mining (NYSE: NEM ) , this phenomenon has reversed for the time being. As of this writing, since the two-day collapse, GLD is up under 7% as compared with a rise of nearly 8.5% for Newmont and a 12.5% surge for Goldcorp. The miners are probably benefiting from the shift toward bullion. If the miners are able to reverse this market preference for gold over gold miners, it could have long-term ramifications for gold in general.
Top 10 Performing Stocks To Buy For 2014: QAD Inc.(QADA)
QAD Inc. provides enterprise software applications, and related services and support for manufacturing companies worldwide. The company offers QAD Enterprise Applications, an integrated suite of software applications, which support the business processes. Its QAD Enterprise Applications include suites, such as QAD Financials to manage and control fiscal business processes at various levels; QAD Customer Management suite for manufacturers to acquire new customers and retain customers through service and support; QAD Manufacturing that offers solutions in the areas of planning and scheduling, cost management, material control, shop floor control, and reporting in various mixed-mode manufacturing environments; and QAD Supply Chain that fulfills materials planning and movement requirements. The QAD Enterprise Applications also comprise QAD Service and Support product suite that handles service calls, manages service queues, and organizes mobile field resources, as well as prov ides project management support; QAD Enterprise Asset Management, an integrated plant operation solution to manage assets from inception through operations and replacement; QAD Transportation Management, which addresses the needs of distributors and manufacturers in the areas of global trade management, freight management, and trade compliance; QAD Analytics that helps in analyses, decision-making, and performance management; and QAD QXtend toolset for open interoperability. The company also provides services, including customer support, implementation services, on demand and application management services, migration and upgrade services, and business process management services. It serves various industries, such as automotive, consumer products, food and beverage, high technology, industrial products, and life sciences industries. The company sells its products directly; and through distributors and sales agents. QAD Inc. was founded in 1979 and is headquartered in Santa Barbara, California.
Top 10 Performing Stocks To Buy For 2014: DCT Industrial Trust Inc (DCT)
DCT Industrial Trust Inc. (DCT) is an industrial real estate company that owns, operates and develops bulk distribution and light industrial properties in distribution markets in the United States and Mexico. The Company is structured as an umbrella partnership real estate investment trust (REIT), under which substantially all of its business is, and will be, conducted through a majority-owned and controlled subsidiary, DCT Industrial Operating Partnership LP (the operating partnership), a Delaware limited partnership, for which DCT Industrial Trust Inc. is the sole general partner. The Company owns properties through its operating partnership and its subsidiaries. As of December 31, 2011, DCT owned approximately 90% of the outstanding equity interests in its operating partnership. In March 2012, DCT acquired a 32.6 acre land parcel in Romeoville, within the southern I-55 industrial submarket of Chicago. In May 2012, the Company acquired two Class A industrial buildings totaling 98,000 square feet in Houston, known as DCT Claymoore Center. Located in the Northwest submarket of Houston, DCT Claymoore Center encompasses a bulk and light industrial facility and is 95.8%-occupied.
During the year ended December 31, 2011, the Company acquired 24 buildings comprising 2.8 million square feet and controlling ownership interests in three buildings totaling 0.4 million square feet. In 2011, the Company sold 16 operating properties totaling approximately 2.7 million square feet to third-parties. As of December 31, 2011, the Company�� consolidated operating properties had leases with approximately 900 customers with no single customer accounting for more than 1.7% of the total annualized base rents of its properties. As of December 31, 2011, the Company owned interests in, managed or had under development approximately 75.5 million square feet of properties leased to approximately 900 customers, including 58.1 million square feet comprising 408 consolidated properties owned in its operating portfo! lio, which were 90.6% occupied; 0.2 million square feet comprising one consolidated property under redevelopment, and 17.2 million square feet comprising 52 unconsolidated properties, which were 86.3% occupied and one managed-only property operated on behalf of five institutional capital management partners. As of December 31, 2011, its total consolidated portfolio consisted of 409 properties with an average size of 142,000 square feet and an average age of 20.2 years.
Advisors' Opinion:- [By Brad Thomas]
Other REITs mentioned: (O), (NNN), (STAG), (DCT), (EGP), (PDM), (DRE), (LRY)
Source: Chambers Street: More Liquidity Magic On The Way In REIT-DomDisclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. (More...)
Top 10 Performing Stocks To Buy For 2014: Design Studio Furniture Mfrltd (D11.SI)
Design Studio Furniture Manufacturer Ltd, together with its subsidiaries, engages in the manufacture, supply, and installation of paneling products primarily in Singapore, Malaysia, and the United Arab Emirates. It operates in three segments: Residential Property Projects, Hospitality and Commercial Projects, and Distribution Projects. The Residential Property Projects segment is involved in the manufacture, supply, and installation of paneling products, such as kitchen and vanity cabinets, wardrobes, doors and door frames, and furniture components. The Hospitality and Commercial Projects segment provides interior fitting-out services to hotels, resorts, office, shops, and bank branches. The Distribution Projects segment engages in the distribution of furniture products of various brands. The company offers its products and services under the in-house brand names of PANELZ, i.FORMZ, and GLITZ; and imported brand names of Siematic and Corian. The company was founded in 1994 and is headquartered in Singapore. Design Studio Furniture Manufacturer Ltd is a subsidiary of Depa Interiors LLC.
No comments:
Post a Comment